What Can Pharmacy Chains Gain From Rite Aid’s Closures?

The drugstore and pharmacy space has faced significant challenges in recent years, and recently, Rite Aid announced that it would be closing all its locations. We took a look at the location intelligence for Rite Aid and the chains buying its closing locations to see how this closure might affect visits to the other chains.

Visits to Drugstores Dip

The past few years have seen a dramatic shift in the way people purchase their prescriptions and other health-related sundries – and Rite Aid, in particular, was heavily affected by this shift. The chain had made several attempts over the past few years to rightsize and restructure in hopes of turning around its fortunes. But in May 2025, amidst bankruptcy proceedings, the company announced it would be closing all of its remaining locations and selling its business  – primarily to CVS Pharmacy, with some going to Walgreens, Albertsons, Kroger, and Giant Eagle.

Rite Aid had already spent much of 2023 and 2024 closing stores, a factor that certainly fueled its 37.2% year-over-year (YoY) dip in foot traffic in Q1 2025. Meanwhile, CVS – which has also been closing stores  – saw its visits and visits per location grow in Q1 2025, by 2.6% and 5.1%, respectively. And Walgreens, in the midst of its own rightsizing moves, experienced relatively flat visit numbers, with only minor YoY dips.

What Does CVS Stand to Gain? 

CVS is poised to be a major beneficiary of Rite Aid’s closure, taking over business from hundreds of its locations. And a look at demographic and psychographic data shows that the move stands to offer CVS greater access to older consumers – a key demographic in the pharmacy space. Rite Aid’s stores also attract a more middle-income shopper, helping to broaden CVS’ customer base.

Rite Aid’s Largest Markets 

A look at geographic segmentation data shows that CVS’s assumption of Rite Aid business will also grant it greater inroads into semirural and urban audiences. 

Rite Aid has its largest presence in California (347 stores), Pennsylvania (345 locations), and New York (178 stores). And data from Esri: Tapestry Segmentation highlights differences in where shoppers at the two drugstore chains tend to come from – both nationwide and in its major markets. 

CVS sees higher shares of “Suburban Periphery” visitors in all the analyzed markets, while Rite Aid sees higher shares of “Semirural” visitor segments, both nationwide and across its largest markets. This reinforces that CVS stands to significantly expand its footprint in less dense, semi-rural communities by acquiring Rite Aid assets.

While some common threads can be seen across visitor types by state, there are also notable differences, highlighting the importance of diversification across geographic segments for comprehensive market coverage. For instance, in New York, Rite Aid holds a higher share of visitors from “Principal Urban Centers” (18.8%) than CVS (13.3%). This suggests CVS may be able to expand both its semirural and urban reach as it assumes Rite Aid's former customer base.

What Lies Ahead For Pharmacy?

Rite Aid’s closure highlights the challenges facing the retail healthcare segment – but it also opens up new opportunities for other chains as they absorb these closed stores. 

What will the retail pharmacy and healthcare segment look like in the coming months? Visit Placer.ai/anchor for the latest data-driven retail insights.